The reimbursement ratio of liraglutide for medical insurance is as follows:

1. Liraglutide is not included in the drug list of basic medical insurance, so its medical expenses are not paid by the basic medical insurance fund;

2. The drugs and medical services covered by the basic medical insurance must meet the standards stipulated by the state and be directly settled with medical institutions and drug business units;

3. If the medical expenses should be borne by a third party, the basic medical insurance fund can pay in advance and then recover from the third party;

4. The basic medical insurance does not include the expenses paid by the industrial injury insurance fund, the expenses borne by the third party, the expenses borne by the public health and the expenses for overseas medical treatment.

medical insurance policy of liraglutide:

1. Medical insurance catalogue: check whether liraglutide is included in the local medical insurance drug catalogue;

2. Reimbursement conditions: Understand the reimbursement conditions of liraglutide, such as indications and doctor's prescription requirements;

3. Reimbursement ratio: inquire about the specific reimbursement ratio of liraglutide, which may be different due to different regions and types of medical insurance;

4. Out-of-pocket ratio: define the proportion of expenses that patients need to bear when using liraglutide;

5. annual capping line: master the annual reimbursement capping line of medical insurance to calculate the possible reimbursement amount;

6. Drug restriction: confirm whether there are any restrictions on drug use, such as restricting hospitals or limiting doctors to prescribe drugs;

7. reimbursement process: understand the specific process of reimbursement for liraglutide, including the materials and steps to be submitted.

To sum up, liraglutide, as a drug not covered by the drug list of basic medical insurance, cannot be paid by the basic medical insurance fund for its medical expenses; At the same time, the basic medical insurance only covers drugs and medical services that meet the national standards, and directly settles with medical institutions and pharmaceutical business units, excluding industrial injury insurance, third-party liability, public health and overseas medical treatment.

Legal basis:

Article 28 of the Social Insurance Law of the People's Republic of China

Medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency and rescue shall be paid from the basic medical insurance fund in accordance with state regulations.